A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic Leukemia

Clinical trial NCT00431873 · COMPLETED

Trial details

NCT number: NCT00431873
Sponsor: Mirati Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphocytic Leukemia, Chronic

Start date: 2007-01-01
Primary completion: 2008-11-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.